What is Eastgate Biotech Corp. (ETBI) stock price today?

Eastgate Biotech Corp. (ETBI) is currently trading at $0.00.

What is ETBI P/E ratio?

Eastgate Biotech Corp.'s P/E ratio is -1.58. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ETBI return on equity (ROE)?

Eastgate Biotech Corp.'s return on equity (ROE) is 40.00%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Eastgate Biotech Corp.'s market cap?

Eastgate Biotech Corp. has a market capitalization of $6.17M.

OTC · Medical - Pharmaceuticals

Eastgate Biotech Corp. (ETBI) Stock

$0.00 OTC: ETBI Healthcare

EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals.

Valuation

Metric	Value
Price	$0.00
Market Cap	$6.17M
P/E Ratio	-1.58
P/B Ratio	-0.59
P/S Ratio	23.06
EPS (TTM)	$-0.01
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	40.00%
ROA	-400.00%
ROCE	33.81%
Gross Margin	-8.45%
Operating Margin	-7439.63%
Net Margin	0.00%
Debt/Equity	-0.50
Current Ratio	0.02

Annual Financials (USD)

Metric	2015	2016	2017	2018	2019
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-4.0M	$-3.0M	$-3.0M	$-1.0M	$-3.0M
Net Profit	$-4.0M	$-3.0M	$-4.0M	$-1.0M	$-4.0M
EPS	$-0.02	$-0.01	$0.00	$0.00	$0.00
Op Margin	-3159.5%	—	-2180.3%	-989.1%	-3282.4%

Balance Sheet (USD)

Metric	2015	2016	2017	2018	2019
Total Assets	$0	$0	$2.0M	$1.0M	$1.0M
Total Liabilities	$3.0M	$5.0M	$7.0M	$9.0M	$11.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$1.0M	$2.0M	$3.0M	$4.0M	$5.0M

Cash Flow (USD)

Metric	2015	2016	2017	2018	2019
Operating Cash Flow	$-1.0M	$0	$-1.0M	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$1.0M	$1.0M
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-1.0M	$0	$-1.0M	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.23
EV / EBITDA	-3.44
FCF Yield	0.98%
Quick Ratio	0.00
Interest Coverage	-12.10
Return 1Y	-25.00%
Return 3Y	50.00%
Return 5Y	200.00%

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
Associated Banc-Corp	288,600	2024-12-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BIOEBio Essence Corporation	$0.25	+37.44%	7.44	$9.90M	0.00%
CBDLCBD Life Sciences Inc.	$0.00	—	-29.85	$375394	0.00%
ERGOEntia Biosciences, Inc.	$0.00	—	0.00	$6732	0.00%
HESGHealth Sciences Group, Inc.	$0.00	—	0.00	$1.87M	0.00%
INBPIntegrated BioPharma, Inc.	$0.16	+2.49%	-3.08	$5.09M	0.00%

About Eastgate Biotech Corp.

EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often lead to detrimental side effects and unforeseen issues for individuals seeking to achieve and maintain good health. Among its diverse product line are E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze, and Warts X. EastGate Biotech's development process involves integrating product components into various nano-sized delivery systems. These systems include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and complex combinations of polymers, lipids, and surfactants (such as hybrid nanoparticles, nanocapsules, and mixed micelles). The company has operational bases in prominent cities including New York, London SF, Cockfosters BP, Los Angeles, Chicago, and Las Vegas.

Eastgate Biotech Corp. (ETBI) stock trades at $0.00 with a market capitalization of $6.17M. The stock is valued at a price-to-earnings (P/E) ratio of -1.58, price-to-book of -0.59, price-to-sales of 23.06. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Eastgate Biotech Corp. generates a return on equity (ROE) of 40.00% — well above the market average, a sign of a high-quality business, return on capital employed of 33.81%, an operating margin of -7439.63%, a net profit margin of 0.00%.

Official website: www.EastGateBiotech.com